The First International Pharmaceutical Compliance Congress and Best Practices Forum was held in June 2007 to bring together company compliance professionals, regulators, lawyers, and consultants working in this interesting and expanding field. The purpose was to hold a truly global conference, addressing the key issues of the day. The first international conference agenda was developed with inputs from company compliance professionals around the topics they wanted to know more about, which continues to be one of the great strengths of these conferences.
Since then, the International Compliance Congress has evolved to encompass global topics in the Plenary Sessions and more locally-focused issues in the Mini Summits as pertinent to the European Union (EU), Central and Eastern Europe (CEE), and the Middle East and Africa (MEA) regions. The 2016 conference continues this trend.
Over the past decade, the international conferences have been held in Brussels (2007, 2015), Paris (2008), Rome (2009), Berlin (2010), Istanbul (2011), Budapest (2012), Madrid (2013) and Dubai (2014). In 2016 we are pleased to hold The Tenth International Pharmaceutical Compliance Congress and Best Practices Forum in Warsaw, Poland with the local partnership of INFARMA, the Employers' Union of Innovative Pharmaceutical Companies. The Congress sponsor remains The International Society of Healthcare Ethics and Compliance Professionals (ETHICS) with the Pharmaceutical Compliance Forum (PCF) as a co-sponsor.
The Congress will feature the following plenary sessions and mini summits:
|
FEATURING PLENARY SESSIONS
|
- Transparency International Keynote
- Overview of the Anti-Corruption Landscape
- The National Anti-Corruption Strategy of Romania
- US Department of Justice Anti-Corruption Update
- Anti-Corruption Roundtable: Strategies to Foster Compliance
- Challenges in the New Marketplace 2.0
- Ethics and the Current Industry-Physician Relationship Model-- Are They Compatible?
- EFPIA Keynote: Reflections on the Eve of Transparency
- Perspectives on Transparency from the Local Country Level: Voices From Poland
- Global Compliance Officer Roundtable: Key Risks for the Industry and the Future of Ethics and Compliance Programs
- Report from Compliance Survey Commissioned by ETHICS
- Updates on Global Codes
|
|
|
AND MINI SUMMITS
|
- I: Anti-Corruption Case Study: Examining a Hypothetical Investigation from All Sides
- II: Annual CEE Compliance Update
- III: Ethics and Compliance Programs of the Future: New Strategies for Integrated Assessment and Management of Risks
- IV: Patient Programs -- Managing the Various Risks of Getting Closer to the Patient
- V: Annual MEA Compliance Update
- VI: Anti-Corruption Case Study: Contracting with Third Parties and Optimizing the Relationship
- VII: New Marketplace Case Study: Ensuring a Compliant Product Launch
- VIII: Data Privacy Case Study: Evolving Requirements for Data Protection and Transfers
- IX: Implementation of Compliance Programs across Different Countries -- Cultural Implications
- X: Using Predictive Analytics to Enhance Risk Management
- XI: Advanced Issues in Third Party Relationships: Cross-Border Engagements, Fair Market Value, Monitoring and Auditing of On-Going Relationships
- XII: New Ethics-Based Approaches to Policies and Training
- XIII: Medical Devices: The Changing Enforcement Landscape
- XIV: R&D Compliance -- Case Study on Clinical Trial Data Disclosures
- XV: Advanced Issues In Applying Analytics -- Using the Data to Provide Value and Partner with the Business
|
|
